drugset
drugset / Trial / NCT06955104

Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia

NCT06955104 ↗

Phase 3 Completed 145 enrolled JW Pharmaceutical
RandomizedParallel-groupQuadruple-blindTreatment

Summary

A Multi-center, Randomized, Double-blind, Parallel, Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients with Dyslipidemia

Timeline

Start
2025-04-03
Primary completion
2025-07-30
Completion
2025-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject C2407 Unknown — —
Subject JW0108 Unknown — —

Indications

hyperlipidemia